These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 32867)

  • 1. Naloxone's antagonism of rigidity but not explosive motor behavior: possible evidence for two types of mechanisms underlying the actions of opiates and opioids.
    Blair R; Cytryniak H; Shizgal P; Amit Z
    Behav Biol; 1978 Sep; 24(1):24-31. PubMed ID: 32867
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential motor effects of intraventricular infusion of morphine and etonitazene.
    Shizgal P; Sklar LS; Brown ZW; Amit Z
    Pharmacol Biochem Behav; 1977 Jan; 6(1):17-20. PubMed ID: 15285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphine and naloxone's effects on sexual behavior of the female golden hamster.
    Ostrowski NL; Stapleton JM; Noble RG; Reid LD
    Pharmacol Biochem Behav; 1979 Dec; 11(6):673-81. PubMed ID: 575426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of opioid receptors in shaking behaviour induced by paraquat in rats.
    Hara S; Iwata N; Kuriiwa F; Kano S; Kawaguchi N; Endo T
    Pharmacol Toxicol; 1993 Sep; 73(3):146-9. PubMed ID: 8265517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploration and motor activity after intraventricular ACTH, morphine and naloxone.
    File SE; Clarke A
    Behav Brain Res; 1981 Mar; 2(2):223-7. PubMed ID: 6264931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spinal interactions between opioid and noradrenergic agonists in mice: multiplicativity involves delta and alpha-2 receptors.
    Roerig SC; Lei S; Kitto K; Hylden JK; Wilcox GL
    J Pharmacol Exp Ther; 1992 Jul; 262(1):365-74. PubMed ID: 1378095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Explosive motor behavior, rigidity and periaqueductal gray lesions.
    Blair R; Liran J; Cytryniak H; Shizgal P; Amit Z
    Neuropharmacology; 1978 Mar; 17(3):205-9. PubMed ID: 643164
    [No Abstract]   [Full Text] [Related]  

  • 8. Heroin, but not levorphanol, produces explosive motor behavior in naloxone-treated rats.
    Blair R; Cytryniak H; Shizgal P; Amit Z
    Psychopharmacology (Berl); 1980; 69(3):313-4. PubMed ID: 6774373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some considerations regarding the characterization and interpretation of neuropeptide-induced behavioral changes.
    Segal DS
    Neurosci Res Program Bull; 1978 Dec; 16(4):510-20. PubMed ID: 35764
    [No Abstract]   [Full Text] [Related]  

  • 10. Behavioral effects of morphine, levorphanol, dextrorphan and naloxone in the frog Rana pipiens.
    Pezalla PD; Stevens CW
    Pharmacol Biochem Behav; 1984 Aug; 21(2):213-7. PubMed ID: 6333037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different opioid systems may participate in post-electro-convulsive shock (ECS) analgesia and catalepsy.
    Urca G; Yitzhaky J; Frenk H
    Brain Res; 1981 Aug; 219(2):385-96. PubMed ID: 6266608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonism of morphine analgesia by intracerebroventricular naloxonazine.
    Simone DA; Bodnar RJ; Portzline T; Pasternak GW
    Pharmacol Biochem Behav; 1986 Jun; 24(6):1721-7. PubMed ID: 3016762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that mu-opioid receptors mediate midbrain "stimulation-produced analgesia" in the freely moving rat.
    Millan MJ; Członkowski A; Herz A
    Neuroscience; 1987 Sep; 22(3):885-96. PubMed ID: 2825072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of opiate- and opioid-peptide-induced immobility.
    Browne RG; Derrington DC; Segal DS
    Life Sci; 1979 Mar; 24(10):933-41. PubMed ID: 36533
    [No Abstract]   [Full Text] [Related]  

  • 15. Opiate effects after adrenocorticotropin or beta-endorphin injection in the periaqueductal gray matter of rats.
    Jacquet YF
    Science; 1978 Sep; 201(4360):1032-4. PubMed ID: 210506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of mu opioid binding sites in rat spinal cord by chronic intrathecal infusion of morphine and naloxone: a quantitative autoradiography approach.
    Gouarderes C; Jhamandas K; Zajac JM; Beaudet A; Cros J; Quirion R
    Prog Clin Biol Res; 1990; 328():175-8. PubMed ID: 2154775
    [No Abstract]   [Full Text] [Related]  

  • 17. Central effects of a selective delta-opioid receptor antagonist, ICI 174864.
    Herman ZS; Stańda J; Janas P; Gołba K
    Pol J Pharmacol Pharm; 1986; 38(5-6):455-60. PubMed ID: 3575165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of morphine analgesia by lithium: role of peripheral and central opioid receptors.
    Johnston IN; Westbrook RF
    Behav Brain Res; 2004 May; 151(1-2):151-8. PubMed ID: 15084430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential actions of intrathecal naloxone on blocking the tail-flick inhibition induced by intraventricular beta-endorphin and morphine in rats.
    Tseng LF; Fujimoto JM
    J Pharmacol Exp Ther; 1985 Jan; 232(1):74-9. PubMed ID: 3155550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of morphine analgesia by LPS: role of opioid and NMDA receptors and spinal glia.
    Johnston IN; Westbrook RF
    Behav Brain Res; 2005 Jan; 156(1):75-83. PubMed ID: 15474652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.